首页 › 基金 › BRAUN STACEY ASSOCIATES INC › ASND

BRAUN STACEY ASSOCIATES INC 对 ASND 的持仓历史

ASCENDIS PHARMA A/S · 医疗保健

BRAUN STACEY ASSOCIATES INC 在 Q3 2026 的 13F 申报中披露持有 ASND(ASCENDIS PHARMA A/S)133,224 股,市值约 US$30.4M,约占其申报组合的 0.87%,在其申报持仓中市值排名第 41 位。 BRAUN STACEY ASSOCIATES INC 最近 5 个申报季度中有 5 个季度披露了 ASND 持仓,最早可追溯至 Q3 2025。

最新持仓 (Q3 2026)133.22K 股
申报持仓市值$30.35M
组合权重0.87%
首次申报Q3 2025
最近变动持有
更新于2026-10-21

最后更新: 2026-10-21 · 来源: SEC EDGAR Form 13F-HR

BRAUN STACEY ASSOCIATES INC 对 ASND 的持仓演变

BRAUN STACEY ASSOCIATES INC 于 Q3 2025 首次披露 ASND 持仓:93,947 股(约 US$18.7M)。 该持仓在 Q2 2026 达到峰值 132,682 股,市值约 US$35.4M。 在 5 次申报中,BRAUN STACEY ASSOCIATES INC 3 次增持、0 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 133,224 股、市值约 US$30.4M。 持仓曾出现大幅变动:Q4 2025 增持约 27% (随后一个季度股价上涨 7%)。

逐季持仓明细

季度股数金额变化
Q3 2025 93.95K $18.68M 新进
Q4 2025 119.09K $25.40M 增持
Q1 2026 130.99K $29.96M 增持
Q2 2026 132.68K $35.39M 增持
Q3 2026 133.22K $30.35M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ASND 与 13F 数据

ASND(ASCENDIS PHARMA A/S)属于医疗保健行业。我们追踪的基金中还有 43 只申报持有 ASND,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ASND 的基金

查看 ASND 的全部基金持有人 →

常见问题

How long has BRAUN STACEY ASSOCIATES INC held ASND?

BRAUN STACEY ASSOCIATES INC has disclosed ASND holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is BRAUN STACEY ASSOCIATES INC's current position in ASND?

As of Q3 2026, BRAUN STACEY ASSOCIATES INC holds 133.22K shares of ASND (ASCENDIS PHARMA A/S), valued at $30.35M, representing 0.87% of its reported portfolio and ranking #41.

Has BRAUN STACEY ASSOCIATES INC been buying or selling ASND?

In the latest 13F filing (Q3 2026), BRAUN STACEY ASSOCIATES INC held unchanged its position in ASND. The position peaked in Q2 2026 at 132.68K shares.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.